Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
- Referrals to patient-related programs or resources
- Donations, website, or event-related assistance
- Tobacco-related topics
- Volunteer opportunities
- Cancer Information
For medical questions, we encourage you to review our information with your doctor.
Research We Fund: Extramural Discovery Science
- Discovery Boost Grants (DBG)
- Arizona (AZ) Discovery Boost Grants (DBG)
- Mission Boost Grants (MBG)
- Research Scholar Grants
- Postdoctoral Fellowships
- Clinician Scientist Development Grant (CSDG)
- ASTRO-ACS Clinician Scientist Development Grant (CSDG)
- Institutional Research Grants
- RFA: Leukemia Exploration and Prevention Grant Program (LEAP)
- RFA: ACS IMPACT - Expanding Prostate Cancer Clinical Trials in the Community
- RFA: Extramural Discovery Science Accelerator Award
- RFA: Cancer Health Equity Research Centers
- IMPACT RFA to Support Research to Reduce Prostate Cancer Mortality
- RFA: Real-World Data Impact Award (RWIA)
- TheoryLab Collaborative (TLC) Grant
- RFA: The Role of Health Policy and Health Insurance in Improving Access to and Performance of Cancer Prevention, Early Detection, and Treatment Services
- ACS Professor Award
- Extramural Grants Department Staff Contacts
- Definition of Research Areas
- FAQs: ACS Extramural Discovery Science and Grant Application Submissions
- Extramural Priority Research Areas
- Our Grant Process
- American Cancer Society Research Events
- Peer Review Committee for DNA Mechanisms in Cancer (DMC)
- Peer Review Committee for Immunology and Blood Cell Development (IBCD)
- Peer Review Committee for RNA Mechanisms in Cancer (RMC)
- Peer Review Committee for Tumor Biochemistry and Endocrinology (TBE)
- Peer Review Committee for Cancer Cell Biology (CCB)
- Peer Review Committee for Cancer Detection and Progression (CDP)
- Peer Review Committee for Experimental Therapeutics (ET)
- Peer Review Committee for Metastasis and Microenvironment (MM)
- Peer Review Committee for Cancer Prevention and Health Promotion (CPHP)
- Peer Review Committee for Treatment, Palliative Care, and Survivorship Research
- Peer Review Committee for Etiology, Screening, and Early Detection (ESED)
- Peer Review Committee for Healthcare Outcomes, Policy, and Systems Research (HOPS)
- ACS Professor Peer Review Committee
- Peer Review Committee for Institutional Research Grants (IRG)
- Molecular Biology and Biochemistry (PF-MBB)
- Cell Biology and Immunology (PF-CBI)
- Cancer Detection and Experimental Therapeutics (PF-CDET)
- Clinical and Population Sciences (PF-CPS)
- Peer Review Committee for Mission Boost Grants
- Discovery Scientific Council
- Community Research Partner Participation on Grant Peer Review Committees
- American Cancer Society Professors
- Nobel Laureates and the American Cancer Society
FAQs: ACS Extramural Discovery Science and Grant Application Submissions
Extramural Discovery Science (EDS) has 3 scientific programs with 14 peer review committees (PRCs) that cover the cancer research continuum.
What are the 3 EDS Scientific Programs?
Our Scientific Programs:
- Biochemistry and Immunology of Cancer Research
- Cell Biology and Preclinical Cancer Research
- Clinical and Cancer Control Research
What happens if I select a Scientific Program that isn’t the best fit for my proposal?
While your selection helps guide the sorting of applications, we determine the final placement within PRCs to ensure that it's been assigned to the most appropriate one. You'll receive an acknowledgment letter after the application deadline indicating which PRC will review your application.
I’m resubmitting my application. Should I list my previous peer review committee or a new one?
Please use the committee code from your previous submission, even if that committee no longer exists. We’ll assign the application to the PRC with the appropriate expertise. Note that you’ll also need to select the EDS scientific program that’s associated with your selected PRC.
Example: Your application was previously reviewed by Cancer Drug Discovery (CDD), so you should list CDD in ProposalCentral as the previous committee. You also need to select the scientific program Cell Biology and Preclinical Cancer Research.
When are Institutional Research Grant (IRG) applications accepted?
The deadline for IRG applications is April 1. The review of IRGs is managed by the Clinical and Cancer Control Research Program.
I am not eligible based on the grant policies, but I have experienced extenuating circumstances. How do I request an extension to my eligibility?
Send a request for an evaluation of eligibility and any questions to grant.eligibility@cancer.org by:
- September 1 for Fall applications
- February 15 for Spring applications
Attach each of these to the email:
- Letter about the rationale for requesting an exception to the ACS eligibility rules
- Full Curriculum vitae (CV)
- NIH biosketch
If your request is approved, you'll receive a formal letter or email confirming your eligibility to apply.
When you send in your application: In the appendix, add your letter or a copy of the extension-request email.